FDC Ltd.

NSE: FDC | BSE: 531599 | ISIN: INE258B01022 | Industry: Pharmaceuticals
| Mid-range Performer
475.4000 -3.95 (-0.82%)
NSE Aug 01, 2025 15:31 PM
Volume: 81,196
 

logo
FDC Ltd.
11 Nov 2019
475.40
-0.82%
Rudra Shares and Stock Brokers Ltd
Forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmic & First in South East Asia to offer ophthalmic formulations, using Blow-Fill-Seal (BFS) technology. FDC is a fundamentally strong company with huge cash in its balance sheet. The company has good product profile starting with Electral which is the market leader in the ORS segment. Moreover, company continues to report decent operating margins and generates sufficient free cash flow from operations every year where part has been used for buyback in the past, for...
Number of FII/FPI investors decreased from 121 to 113 in Jun 2025 qtr
More from FDC Ltd.
Recommended